Jelena M. Janjic, Ph.D.Associate Professor of Pharmaceutics
Mylan School of Pharmacy
Graduate School of Pharmaceutical Sciences
Education:2001 - 2005: School of Pharmacy, University of Pittsburgh, Pittsburgh, PA PhD in Medicinal Chemistry / Pharmaceutical Sciences (December 8th , 2005) Thesis title: “Design, Synthesis and Biological Evaluation of New Agents Targeting Estrogen Receptor-Alpha and –Beta”
1992 - 1998: Faculty of Pharmacy, Belgrade University, Belgrade, S.R. Yugoslavia Pharmacist (Diplomirani Farmaceut) (October 20th , 1998) Thesis title: “Application of IR Spectroscopy in Drug Analysis”
- 2015-present: Associate Professor, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA
- 2011-present: Founder and Co-Director, Chronic Pain Research Consortium, Duquesne University, Pittsburgh, PA (Link: http://duq.edu/about/centers-and-institutes/chronic-pain-research-consortium )
- 2014-present: Faculty member, McGowan Research Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA (Link: http://www.mirm.pitt.edu/people/bios/Janjic1.asp )
- 2009-2015: Assistant Professor, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA
- 2009-2011: Visiting Scientist, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA
- 2008-2009: Director of Pharmaceutical Chemistry (part time), Celsense Inc., Pittsburgh, PA
- 2006-2008: Senior Research Scientist (part time), Celsense Inc., Pittsburgh, PA
- 2006-2009: Research Biologist (full time), Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA
- 2005-2006: Post-Doctoral Research Associate, Scripps Florida, Jupiter, FL, USA
- 2001-2005: Teaching Fellow, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA
- 2000-2001: Research Specialist, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
- 1999-2000: Pharmacist, Labud-Pharmacy, Belgrade, S.R. Yugoslavia
- 1998-1999: Pharmacist-Administrator, National Reserves of the Republic of Serbia, Belgrade, S.R. Yugoslavia
Design and synthesis of novel drug delivery formulations with focus on liquid and semisolid dosage forms and nanosystems; Design, synthesis, and biological evaluation of theranostic dosage forms (nanoemulsions, nanogels, gels, capsules, etc.) for imaging and treatment of inflammation in varied pathological states (cancer, neuronal injury, inflammatory bowel disease, muscle diseases); Applying theranostics and nanotechnology to studying immune system and nervous system interplay in chronic pain; Development of nanotechnology based therapeutic interventions for chronic pain.
2015-2017 R21 DA039621-01 National Institute on Drug Abuse
Project Title: "Theranostic Pain Nanomedicines: imaging inflammation, reducing pain and need for opioids."
Role: Principal Investigator
Co-Is: Pollock, J.A. and Kolber, B. (Biology, Duquesne University)
2014-2016 The Provost's Office Interdisciplinary Research Consortia Seed Funds for the support of the Chronic Pain Research Consortium at Duquesne University
Founder and Co-Director (award Co-PI): Jelena M. Janjic, PhD (Pharmacy)
Co-Director (award Co-PI): John A. Pollock, PhD (Biological Sciences, BSNES)
Research and Education Coordinator (award Co-I): Benedict Kolber, PhD (Biological Sciences, BSNES) Grant and Funding Coordinator (award Co-I): Kevin A. Tidgewell, PhD (Pharmacy)
2014 N00014-14-1-0723 Office of Naval Research
Project Title: Acquisition of a shear rheometer for research on tissue scaffold ECM hydrogels and other biomaterials
PI: Sachin Velankar, PhD (Swanson School of Engineering, University of Pittsburgh)
Role: Co-Investigator, (theranostic hydrogels design and development, rheological assessment of complex hydrogels)
2011-2014 1R15AI081218-01A2 NIH, NIAID (National Institute of Allergy and Infectious Diseases)
Project Title: "Non-viral Genetic Modification of Antigen-presenting Cells in Allografts"
PI: Wilson Meng, PhD (Pharmacy, Duquesne University)
Role: Co-Investigator, Imaging support (MRI/optical reagent design and development, in vitro assessment)
2011-2013 Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund
Project Title: "Acute to Chronic Pain Transition in Postsurgical Recovery: Combined input from immune system and peripheral nervous system"
Role: Partnering PI (with John Pollock, PhD)
2011-2013 Pennsylvania State Health Formula Research Grants Program (C.U.R.E. Award) Project Title: "From Insoluble Perfluorocarbon Oils to Multifunctional Nanoparticles for Breast Cancer Imaging and Treatment"
Role: Principal Investigator
2010-2012 Faculty Development Funds, Duquesne University
Project Title: "Perfluorocarbon nanoemulsions for simultaneous delivery of COX2 inhibitor and antiproliferative agents to breast tumors"
Role: Principal Investigator
2009-2010 STTR, 1R41EB009618 - 01A1 NIH, NIBIB (National Institute of Biomedical Imaging and Bioengineering)
Project Title: "Dual Mode Nanoemulsions for 19F MRI and Fluorescence Detection"
Role: Principal Investigator (Consortium with Celsense Inc, Pittsburgh PA)
1. L. Liu, C. Bagia, JM Janjic* "The First Scale up Production of Theranostic Nanoemulsions" Bioresearch Open Access 2015, 4(1): 218-228. (Invited Paper)
2. S.K. Patel, W. Beaino, C.J. Anderson*, J.M. Janjic* Theranostic Nanoemulsions for Macrophage COX-2 Inhibition in a Murine Inflammation Model Clinical Immunology 2015, epub May 8, 2015
3. K Vasudeva, Y Vodovotz, N Azhar; D Barclay; JM Janjic, JA Pollock* "In Vivo and Systems Biology Studies Implicate IL-18 as a Central Mediator in Chronic Pain" Journal of Neuroimmunology 2015, 283, 43-49
4. Y. Wen, W. Liu, C. Bagia, S. Zhang, M. Bai, J.M. Janjic, N. Giannoukakis, E. S Gawalt, W.S. Meng* "Antibody-Functionalized Peptidic Membranes for Neutralization of Allogeneic Skin Antigen-Presenting Cells" Acta Biomaterialia 2014, 10 (11), 4759-4767
5. N. Jia, S. Zhang, P. Shao, C. Bagia, J.M. Janjic, Y. Ding, and M. Bai* "Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth." Molecular Pharmaceutics 2014, 11 (6), 1919-1929
6. J.M. Janjic*, P. Shao, S. Zhang, X. Yang, S.K. Patel, M. Bai* "Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties" Biomaterials 2014, 35 (18), 4958-4968
7. G.A. Mountain, B.J. Jelier, C. Bagia, C.M. Friesen, J.M. Janjic* "Design and formulation of nanoemulsions using 2-(poly (hexafluoropropylene oxide)) perfluoropropyl benzene in combination with linear perfluoro (polyethylene glycol dimethyl ether)"Journal of Fluorine Chemistry 2014, 162, 38-44
8. K. Vasudeva, K. Andersen, B. Zeyzus-Johns, T.K. Hitchens, S.K. Patel, A. Balducci, J.M. Janjic, J. A. Pollock* "Imaging Neuroinflammation In Vivo in a Neuropathic Pain Rat Model with Near-Infrared Fluorescence and 19F Magnetic Resonance" PloS one 2014, 9 (2), e90589
9. M.J. Patrick, J.M. Janjic, H. Teng, M.R. O'Hear, C.W. Brown, J.A. Stokum, B.F. Schmidt, E.T. Ahrens*, A.S. Waggoner "Intracellular pH measurements using perfluorocarbon nanoemulsions" Journal of the American Chemical Society 2013, 135 (49), 18445-18457.
10. S.K. Patel, J. Williams, J.M. Janjic* "Cell labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design" Biosensors 2013, 3(3), 341-359
11. S.K. Patel, M.J. Patrick, J.A. Pollock, J.M. Janjic* "Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemulsions" Journal of Biomedical Optics 2013, 18 (10), 101312
12. J.M. Janjic*, S.K. Patel, M.J. Patrick, J.A. Pollock, E. DiVito, M. Cascio "Suppressing inflammation from inside out with novel NIR visible perfluorocarbon nanotheranostics" (Invited Paper) Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2013, 8596, art. no. 85960L
13. S.K. Patels, Y. Zhang, J.A. Pollock, J.M. Janjic* "Cyclooxygenase-2 Inhibiting Perfluoropoly (ethylene glycol) ether Theranostic Nanoemulsions - In Vitro Study" PloS one 2013, 8(2):e55802.
14. A. Balducci, Y. Wen, Y. Zhang, B.M. Helfer, T.K. Hitchens, W.S. Meng, A.K. Wesa, J.M. Janjic* "A novel probe for the non-invasive detection of tumor-associated inflammation" Oncoimmunology 2013, 2 (2), e23034
15. C.E. O'Hanlon, K.G. Amede, M.R. O'Hear, J.M. Janjic* "NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging" Journal of Fluorine Chemistry 2012, 137, 27-33
16. T.K. Hitchens, Q. Ye, D.F. Eytan, J.M. Janjic, E.T. Ahrens, C. Ho* "19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells" Magnetic Resonance in Medicine 2011, 65, 1144-1153
17. D.K.K. Kadayakkara, J.M. Janjic, L.K. Pusateri, W.B. Young, E.T. Ahrens "In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI" Magnetic Resonance in Medicine 2010, 64,1252-1259
18. B. Helfer, A. Balducci, A. Nelson, J.M. Janjic, R.R. Gil, P. Kalinski, J. M. de Vries, E.T. Ahrens, R. Mailliard, "Functional assessment of human dendritic cells labeled for in vivo 19F MRI cell tracking" Cytotherapy 2010, 12, 238-250.
19. D.K.K. Kadayakkara, P. Beatty, J.M. Janjic, M. Turner, E. Ahrens, O. Finn "Inflammation driven overexpression of the hypoglycosylated abnormal MUC1 links inflammatory bowel disease (IBD) and pancreatitis" Pancreas 2010, 39, 510-515
20. M. Srinivas, M.S. Turner, J.M. Janjic, P.A. Morel, D.H. Laidlaw, E.T. Ahrens "In vivo cytometry of antigen specific T-cells using 19F MRI" Magnetic Resonance in Medicine 2009, 62, 747-753
21. J.M. Janjic, M. Srinivas, D.K.K. Kadayakkara, E.T. Ahrens "Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection", Journal of American Chemical Society 2008, 130, 2832-2413.
22. Sarachine, M.J.; Janjic, J.M.; Wipf, P; Day, B.W. "Biphenyl C-cyclopropylalkylamides as new scaffolds for targeting estrogen receptor β" Bioorganic Medicinal Chemistry Letters 2009, 19, 2404-2408. (Impact factor: 2.338, cited 2 times)
23. Wipf, P.; Coleman, C.M.; Janjic, J.M.; Iyer, P.S.; Fodor, M.D.; Shafer, Y. A. Stephenson, C.R. J.; Kendall, C.; Day, B.W. "Microwave-Assisted "Libraries from Libraries" Approach toward the Synthesis of Allyl- and C-Cyclopropylalkylamides," Journal of Combinatorial Chemistry 2005, 7, 322-330.
24. Janjic, J.M.; Mu, Y. ; Kendall, C.; Stephenson, C.R. J.; Balachandran, R.; Raccor, B. S. ; Lu, Y.; Zhu, G.; Xie, W.; Wipf, P.; Day, B. W. "New Antiestrogens from a Library Screen of Homoallylic Amides, Allylic Amides and C-Cyclopropylalkylamides," Bioorganic and Medicinal Chemistry 2005, 13, 157-164.
25. Wipf, P.; Janjic, J.M.; Stephenson, C.R. "Microwave-assisted synthesis of allylic amines: considerable rate acceleration in the hydrozirconation-transmetalation-aldimine addition sequence," Organic and Biomolecular Chemistry 2004, 2, 443-445.
26. Lu, G.; Janjic, B.M.; Janjic, J.; Whiteside, T.L.; Storkus, W.J.; Vujanovic, N.L. "Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1), -beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand," Journal of Immunology 2002, 168, 1831-1839.
Book chapters and reviews
27. S.K. Patel and J.M. Janjic* "Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases" Theranostics 2015
28. J.M. Janjic* and M. Bai "Design and Development of Theranostic Nanomedicines" Chapter in: Nanotechnology for Biomedical Imaging and Diagnostics: From Nanoparticle Design to Clinical Applications, Edited by Mikhail Berezin, John Wiley & Sons, Inc; 2014
29. J.M. Janjic, E.T. Ahrens "Fluorine-containing nanospheres for MRI" Advanced Reviews, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Sept./Oct. 2009, 1, 492-501
30. Wipf, P.; Gong, H.; Janjic, J.M.; Li, S.; Day, B.W.; Xie, W. "New Opportunities for pregnane X receptor (PXR) targeting in drug development. Lessons from enantio- and species-specific PXR ligands identified from a discovery library of amino acid analogues" Mini Reviews Medicinal Chemistry 2007, 7, 617-625
33. E.T. Ahrens and J.M. Janjic "Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications" 2013, USP Application number 20130343999, Assignee Celsense Inc.
34. J.M. Janjic and E.T. Ahrens "Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques" 2012, USP 8,227,610, Assignee Carnegie Mellon University
National and International
1. Janjic J.M. Triphasic (Fluorous/Organic/Aqeous) Nanoemulsions as a Theranostic Nanomedicine Platform for Inflammatory Diseases, 21st International Symposium on Fluorine Chemistry which is organized jointly with the International Symposium on Fluorous Technologies 2015 in Como (Italy) from 23rd-28th August 2015 (invited)
2. Janjic J.M. Perfluorocarbons Revisited: Pharmaceutical Approach to Cancer and Inflammation Theranostics Development Department of Radiation Oncology Visiting Lecturer Aug. 6-7, 2015, Washington University School of Medicine in St. Louis, St. Louis, hosted by Prof. Chairman Dennis Hallahan, MD
Elizabeth H. and James S. McDonnell III Distinguished Professor of Medicine, Chairman, Department of Radiation Oncology and Dr. Michael Gach, Radiation Oncology
3. Janjic J.M. (Chair, Symposia: Expanding the Toolbox: Theranostic Nanomedicine and Systems Biology Applied to Pain Research and Treatment at American Pain Society Scientific National Meeting in Palm Springs, CA, June 13-16th, 2015. Symposia presenters: Prof. Gerard Gebhart, University of Pittsburgh; Prof. Yoram Vodovotz, University of Pittsburgh and Prof. John A. Pollock, Duquesne University and Jelena M. Janjic, Duquesne University.
4. Janjic J.M. (session Chair with J. A. Pollock as Co-Chair) for the working session titled: "Chronic Pain and Inflammation" at McGowan Institute Research Retreat at Nemacolin Woodlands Resort, Farmington, PA, USA March 9-11 2014, Janjic J.M. talk titled: "Theranostic Pain Nanomedicine: Entry to the New Era of Inflammatory Pain Research?"
5. Janjic, J.M. "Perfluorocarbons as a new platform for personalized medicine" 21st Winter Fluorine Conference St. Jan 13-18 2013 Pete's Beach, FL, USA, invited by Prof. Michael Gerken, Conference Chair
6. Janjic, J.M. "Suppressing inflammation from inside out with novel NIR visible perfluorocarbon nanotheranostics" SPIE Photonics West, Feb 2-7 2013 invited by the session chair Walter Akers, PhD, University of Washington School of Medicine, San Francisco, CA
7. Janjic, J.M. "Perfluorocarbons: Promising Materials for Pharmaceutical Process-Friendly Theranostics" UMass Boston Chemistry Colloquium invited and hosted by Prof. Wei Zhang Oct 24th 2012, Boston, MA
8. Janjic, J.M. "From Inert Perfluorocarbons to Theranostic Agents: A road less travelled" Invited lecture at The Faculty of Pharmacy, University of Ljubljana, invited and hosted by Prof. Borut Strukelj, March 3rd, 2011, Ljubljana, Slovenia (EU)
9. Janjic, J.M. "The Road to True Theranostic Nanoreagents is Paved with Perfluorocarbons" Symposium in Honor of Donald J. Burton: Fluorine Chemistry the Iowa Way, American Chemical Society 242nd National Meeting, Aug. 29 - Sept. 1 2011, Denver, CO
10. Janjic, J.M.; Kadayakkara, D.K.K.; Hitchens, K.T.; Ahrens, E.T. "Multispectral 19F MRI Reagents - Design, Synthesis and Biological Evaluation" Fluorine Chemistry Symposia, American Chemical Society 236th National Meeting Aug. 17-21 2008, Philadelphia, PA
11. Janjic, J.M.; Srinivas, M.; Kadayakkara, D.K.K.; Ahrens, E.T. "Synthesis of novel dual-mode 'self-delivering' nanoparticles for in vivo fluorine-19 MRI and fluorescence cell tracking" Joint Molecular Imaging Conference, Sep. 8-11 2007, Providence, RI
Regional and Local
12. Janjic J.M. "Theranostic nanoemulsions in pain and inflammation" October 29th, 2014 Department of Radiology Research Seminar, University of Pittsburgh, host Prof. Carolyn Anderson, Department of Radiology
13. Janjic J.M. "COX-2 Inhibiting Theranostic Nanoemulsions and their Application to Inflammation Investigations from Cancer to Chronic Pain" University of Pittsburgh Cancer Institute Basic & Translational Research Seminar Series, invited and hosted by Dr. Michael Gach, University of Pittsburgh Cancer Institute January 21, 2014, Pittsburgh, PA
14. Janjic J.M. "All Dosage Forms Theranostic; All Medicine Personalized Medicine." Fall 2013 Seminar Series Department of Biological Sciences, BSNES, Duquesne University, invited and hosted by Dr. John Pollock Sept 6th, 2013, Pittsburgh, PA
15. Janjic J.M. "Perfluorocarbon Theranostics for Imaging and Treatment of Inflammation in Preclinical Models" Center for Inflammation and Regeneration Modeling (CIRM), McGowan Institute for Regenerative Medicine, University of Pittsburgh, invited and hosted by Prof. Yoram Vodovotz, May 24th 2012, Pittsburgh, PA
16. Janjic, J.M. "Perfluorocarbon Theranostics: From a Pharmaceutical Scientist's Perspective" invited seminar at University of Pittsburgh School of Medicine, Department of Radiology, invited and hosted by Prof. Mingfeng Bai, PhD Dec 9th 2011, Pittsburgh, PA
Teaching areas: Pharmaceutics, Pharmaceutical Manufacturing, Molecular Imaging, Drug Delivery, Pharmacology, Medicinal Chemistry, Physiology and Pathophysiology.
A. Graduate courses taught (2009 - present)
Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA
GPSC 501 Pharmaceutical Unit Operations and Formulation (1 credit/team taught, 3 cr. course). Formulation and manufacturing of liquids and semisolids
GPSC 508 Pharmaceutical Manufacturing Laboratory (2 credits/team taught, 3 cr. course). Formulation and manufacturing of liquids and semisolids, nanoemulsions project leader, experimental design
GPSC 513 Principles of Drug Action, Design, and Delivery (1 credit/team taught/course master, 3 cr. course). Medicinal chemistry section and drug discovery
GPSC 617 Pharmaceutical Biotechnology (0.5 credit/team taught, 2 cr. course). Design of imaging reagents
GPSC 619 Drug Delivery Systems (1 credit/team taught - course master, 2 cr. course). Drug delivery vehicle design and targeting, focus on cancer therapeutics, theranostics, imaging agents
B. PharmD courses taught (2007 - present)
Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA
PHBM 355 Human Physiology and Pathophysiology I (1.5 credits/team taught, 4 cr. course). Chemistry of life, basic biochemical topics in genetics and pharmacogenetics, genetic diseases
PHBM 442 Biomedical Sciences and Therapeutics: Gastroenterology (0.7 credits/team taught, 3 cr. course). Gastrointestinal disorder therapeutics (medicinal chemistry) and pharmacology
PHBM 442-71 Biomedical Sciences and Therapeutics: Gastroenterology (0.7 credits/team taught, 3 cr. course). Gastrointestinal disorder therapeutics (medicinal chemistry) and pharmacology
BMST 426-71 Biomedical Sciences & Therapeutics: Infectious Disease (2 credits/team taught, 3 cr. course). Medicinal chemistry of infectious disease drugs
BMST 425-71 Biomedical Sciences & Therapeutics: Endocrine/Nutrition (1 credit/team taught, 3 cr. course). Medicinal chemistry of steroid and hormonal drugs
PHPR-427-61/UPNS-491-61 Etiology, Assessment and Treatment of Pain for the Health Care Professional (0.5 credit/team taught, 2 cr. course). Medicinal chemistry of analgesics, inflammation and pain, mindfulness/meditation in pain management. Cross- disciplinary course offered through School of Nursing and School of Pharmacy
School of Pharmacy, University of Pittsburgh, Pittsburgh, PA (2001-2004)
PHARM 5318 Endocrinology, (guest lecturer, 0.5 credit, 3 cr. course). Lectures and practicum on steroid hormones, estrogens, SERMs and breast cancer
• Poloyac, S.M.; Rohan, L.C.; Janjic, J.M.; Gibbs, R.B.; Kroboth, P.D.; Smith, R.B.; "GEAR-UP (Graduate Education And Research at the University of Pittsburgh), A Program for Educating Students about Pharmaceutical Research," American Journal of Pharmaceutical Education 2005, 69, 91-97. (Peer reviewed, journal impact factor: 1.21, co-wrote the paper, co-designed the study, served on the organizational committee of the program 2001-2004)
• Procurement of specialized equipment (Microfluidizer M-110EH-30) and professional training for the graduate course GPSC 508: Pharmaceutical Manufacturing Laboratory (Spring 2014). Microfluidics Corp. and Divitech donated 6 months of unlimited equipment use on site and hands-on student and staff training.
• 2014 - 2019 NIH R25 SEPA "Partnerships in Neuroscience Education."
This award from the Office of the Director is for public science education on issues of neuroscience including pain, learning, and memory using multimedia and digital devices.
PI: John A. Pollock, PhD (Biological Sciences, Duquesne University)
Role: Scientific content editor and advisor
Presentations pertaining to teaching and service
• Janjic, J.M. "Mindfulness in the classroom" Round table discussion/presentation, Wakonse Faculty Conference, May 24-29, 2013, Camp Miniwanca on Lake Michigan. (20 session participants)
• Janjic, J.M. Practice Session "Welcoming the emotional life of teaching through mindfulness practice," at the fifth annual Association for Contemplative Mind in Higher Education Conference, "Integrity of Practice: A Contemplative Vision for Higher Education," Amherst College, Amherst, MA, November 8-10, 2013 (24 session participants)
• Janjic, J.M. "Trusting that you'll get there! From pharmacy school freshman to pharmacy school professor." Career seminar at 2nd Annual MGDB-CBMP Scientific Retreat, University of Pittsburgh, May 31st 2013 at the Hilton Garden Inn Pittsburgh University Place
• Janjic, J.M. "Got some perfluorocarbons? A medicinal chemist's story" April 23rd 2012: University of Pittsburgh School of Pharmacy AAPS student chapter "How we got here: Career development in basic and clinical pharmaceutical sciences", joint alumni and career event with Duquesne University and West Virginia University
• Presentation/practice (Janjic): "Contemplative focus on your story" at the Inspired Teaching Retreat May 15-16, 2014. Theme: What Our Stories Teach Us. Leaders: Jelena M. Janjic (Pharmacy), Matt Kostek (Physical Therapy), Leslie Lewis (Gumberg), Steve Hansen & Laurel Willingham-McLain (Center for Teaching Excellence).
• Presentation/practice (Janjic): "Mindful Teachers" and "Mindful Teaching" at the Inspired Teaching Retreat May 9-10, 2013. Theme: Teaching as Whole Persons. Leaders: Jelena M. Janjic (Pharmacy), Leslie Lewis (Gumberg), Steve Hansen & Laurel Willingham-McLain (Center for Teaching Excellence).
• Presentation/Practice (Janjic): "Mindfulness" at the Inspired Teaching Retreat May 11-12, 2012. Theme: Integrating Life and Learning. Leaders: Susan Goldberg (Psychology) Jelena M. Janjic (Pharmacy), Leslie Lewis (Gumberg), Steve Hansen & Laurel Willingham-McLain (Center for Teaching Excellence).
• Presenters: Steven Hansen (CTE), Ann Marie Hansen (Occupational Therapy) and Jelena M. Janjic (Pharmacy: "Mindfulness: A Practice that Deepens Learning" February 22, 2012. Center for Teaching Excellence Workshop, Duquesne University